The images showed that nearly all the antibodies bind to a single domain of the receptor, providing a viable target for novel therapeutics.
From left: Charles Christoffer, Genki Terashi and Daisuke Kihara of Purdue University launched the high-tech software startup Molecular Intelligence to determine 3D structures of biomolecules. The ...